Integral Health Asset Management, LLC
About Integral Health Asset Management, LLC’s 13F portfolio
Integral Health Asset Management, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Integral Health Asset Management, LLC reported $2.4B across 89 US-listed positions (). Its largest position is REVOLUTION MEDICINES INC (RVMD) at 12% of the reported book, and its ten biggest holdings make up 47% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: RVMD REVOLUTION MEDICINES INC | $159.43 −0.24% | 12% | 1.5M | $280.9M |
| 2 | NASDAQ: INSM INSMED INC | $144.46 +20.58% | 7.0% | 1.6M | $170.6M |
| 3 | NASDAQ: CYTK CYTOKINETICS INC | $51.46 +0.27% | 5.6% | 1.6M | $136.3M |
| 4 | NYSE: CVS CVS HEALTH CORP | $80.04 −1.61% | 4.7% | 1.1M | $113.8M |
| 5 | NASDAQ: EWTX EDGEWISE THERAPEUTICS INC | $41.17 −0.48% | 3.3% | 2.0M | $81.3M |
| 6 | NASDAQ: VERA VERA THERAPEUTICS INC | $26.75 +4.57% | 3.1% | 1.8M | $75.1M |
| 7 | NASDAQ: AXSM AXSOME THERAPEUTICS INC. | $135.68 +1.25% | 3.0% | 300K | $73.4M |
| 8 | NYSE: CAH CARDINAL HEALTH INC | $272.34 −2.15% | 2.9% | 300K | $71.3M |
| 9 | NASDAQ: ROIV ROIVANT SCIENCES LTD | $38.96 +0.59% | 2.9% | 2.0M | $70.8M |
| 10 | NASDAQ: RYTM RHYTHM PHARMACEUTICALS INC | $116.80 −1.88% | 2.5% | 550K | $61.1M |
| 11 | NYSE: EW EDWARDS LIFESCIENCES CORP | $103.88 −1.28% | 2.3% | 625K | $56.5M |
| 12 | NASDAQ: ALHC ALIGNMENT HEALTHCARE INC | $6.50 −3.27% | 2.0% | 2.0M | $47.6M |
| 13 | NYSE: MRK MERCK & CO INC | $132.81 −3.61% | 1.8% | 350K | $45.0M |
| 14 | NYSE: DGX QUEST DIAGNOSTICS INC | $259.09 −0.23% | 1.7% | 200K | $42.4M |
| 15 | NASDAQ: QURE UNIQURE NV | $20.23 −0.34% | 1.7% | 900K | $41.5M |
| 16 | NASDAQ: SRRK SCHOLAR ROCK HLDG CORP | $50.37 +4.94% | 1.7% | 750K | $41.3M |
| 17 | NYSE: BSX BOSTON SCIENTIFIC CORP | $42.99 −1.49% | 1.6% | 900K | $38.4M |
| 18 | NASDAQ: BTSG BRIGHTSPRING HEALTH SVCS INC | $64.02 −6.32% | 1.6% | 550K | $38.4M |
| 19 | NYSE: ABT ABBOTT LABORATORIES | $103.87 −0.58% | 1.5% | 400K | $36.3M |
| 20 | NYSE: UNH UNITEDHEALTH GROUP INC | $330.48 −5.55% | 1.4% | 85K | $35.3M |
| 21 | NASDAQ: LFST LIFESTANCE HEALTH GROUP INC | $13.34 −3.12% | 1.3% | 3.0M | $32.1M |
| 22 | OTC: NVSEF NOVARTIS AG | $156.50 −1.85% | 1.3% | 200K | $31.3M |
| 23 | NASDAQ: TNGX TANGO THERAPEUTICS INC | $22.71 +3.75% | 1.3% | 1.0M | $31.3M |
| 24 | NYSE: THC TENET HEALTHCARE CORP | $263.59 −2.86% | 1.3% | 165K | $30.9M |
| 25 | NASDAQ: SYRE SPYRE THERAPEUTICS INC | $97.63 −3.77% | 1.2% | 325K | $28.9M |
Showing 1–25 of 89 positions on this page reported in this 13F.
- Healthcare97%
- AddedINSMINSMED INC+6.7%$170.6M
- AddedCVSCVS HEALTH CORP+633%$113.8M
- AddedEWTXEDGEWISE THERAPEUTICS INC+25.0%$81.3M
- AddedVERAVERA THERAPEUTICS INC+9.4%$75.1M
- AddedAXSMAXSOME THERAPEUTICS INC.+757%$73.4M
- AddedCAHCARDINAL HEALTH INC+11.1%$71.3M
- AddedEWEDWARDS LIFESCIENCES CORP+268%$56.5M
- AddedDGXQUEST DIAGNOSTICS INC+233%$42.4M
- AddedSRRKSCHOLAR ROCK HLDG CORP+50.0%$41.3M
- AddedBSXBOSTON SCIENTIFIC CORP+63.6%$38.4M
- ReducedRYTMRHYTHM PHARMACEUTICALS INC−8.3%$61.1M
- ReducedALHCALIGNMENT HEALTHCARE INC−22.3%$47.6M
- ReducedMRKMERCK & CO INC−17.6%$45.0M
- ReducedBTSGBRIGHTSPRING HEALTH SVCS INC−56.0%$38.4M
- ReducedLFSTLIFESTANCE HEALTH GROUP INC−30.2%$32.1M
- ReducedNVSEFNOVARTIS AG−20.0%$31.3M
- ReducedREGNREGENERON PHARMACEUTICALS−52.9%$24.9M
- ReducedGKOSGLAUKOS CORP−14.3%$21.0M
- ReducedALMSALUMIS INC−12.5%$19.7M
- ReducedELVELEVANCE HEALTH INC FORMERLY−33.3%$19.3M
Reading Integral Health Asset Management, LLC’s 13F portfolio
Integral Health Asset Management, LLC’s $2.4B 13F book is spread across 89 reported positions and is concentrated toward its biggest ideas, with the top ten holdings at 47%. The largest positions carry real weight, so how those names perform matters a lot to the overall book. Its five largest positions are RVMD, INSM, CYTK, CVS and EWTX, led by REVOLUTION MEDICINES INC (RVMD) at 12% of the portfolio. The heaviest sector exposure is Healthcare (97%).
What Integral Health Asset Management, LLC changed last quarter
Between 2026-03-31 and Q2 2026, Integral Health Asset Management, LLC was roughly balanced between buying and selling: it opened 29 new positions and added to 23 more, while trimming 20 and closing 26 outright. Against a 89-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was INSMED INC (INSM), and its biggest reduction was RHYTHM PHARMACEUTICALS INC (RYTM).
What a 13F does and doesn’t reveal
A 13F captures only Integral Health Asset Management, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Integral Health Asset Management, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Integral Health Asset Management, LLC's profile on this page is built directly from those filings.
How current is the 13F data on Integral Health Asset Management, LLC's page?
It reflects Integral Health Asset Management, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Integral Health Asset Management, LLC files its next quarterly report, this page refreshes automatically.
Can I see Integral Health Asset Management, LLC's complete list of holdings?
This page highlights Integral Health Asset Management, LLC's largest positions rather than all 89 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Integral Health Asset Management, LLC's filings.
Does a 13F show everything Integral Health Asset Management, LLC owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Integral Health Asset Management, LLC's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Integral Health Asset Management, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

